Thymosin Alpha-1 Levels and Daily Rhythms Are Disrupted in Women With Inflammatory Gynecologic Diseases
Women with inflammatory gynecologic diseases showed altered thymosin alpha-1 plasma levels and disrupted circadian patterns compared to healthy women, with changes reflecting inflammation type and treatment response.
Quick Facts
What This Study Found
Thymosin alpha-1 plasma levels and circadian rhythms were altered in gynecologic inflammation, varying by inflammation type and normalizing with successful treatment.
Key Numbers
How They Did This
Cohort study measuring plasma thymosin alpha-1 concentrations at multiple timepoints in women with inflammatory gynecologic diseases compared to healthy controls.
Why This Research Matters
Thymosin alpha-1 as a treatment response biomarker could help clinicians monitor whether gynecologic inflammation therapy is working without invasive procedures.
The Bigger Picture
Immune peptide rhythms are part of normal health. Their disruption in disease and restoration with treatment provides a non-invasive window into immune system status.
What This Study Doesn't Tell Us
Small study with limited abstract details. Specific inflammation types and sample sizes not described. Circadian sampling adds complexity.
Questions This Raises
- ?Can thymosin alpha-1 circadian patterns guide treatment timing?
- ?Do other immune peptides show similar circadian disruption in inflammation?
- ?Could thymosin alpha-1 supplementation restore disrupted immune rhythms?
Trust & Context
- Key Stat:
- Rhythms disrupted Not just thymosin alpha-1 levels but their normal day-night cycling was altered in gynecologic inflammation, reflecting disease state
- Evidence Grade:
- Preliminary clinical evidence with circadian measurements in a relevant patient population, but limited by abstract brevity.
- Study Age:
- Published in 2000. Thymosin alpha-1's role as an immune biomarker has been supported by subsequent research.
- Original Title:
- Changes in thymosin-alpha(1)content in patients with nonspecific gynecologic diseases depending on inflammation type and efficacy of antiinflammatory and immunomodulating therapy.
- Published In:
- Bulletin of experimental biology and medicine, 130(9), 895-7 (2000)
- Authors:
- Shurlygina, A, Litvinenko, G, Dergacheva, T, Trufakin, V
- Database ID:
- RPEP-00619
Evidence Hierarchy
Frequently Asked Questions
What does thymosin alpha-1 tell doctors about inflammation?
When its normal daily rhythm is disrupted and levels are abnormal, it indicates the immune system is fighting inflammation. When levels normalize with treatment, it suggests the therapy is working.
Could this replace invasive tests?
Potentially. A blood test tracking thymosin alpha-1 rhythms could monitor treatment response non-invasively, reducing the need for biopsies or imaging in some gynecologic inflammatory conditions.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00619APA
Shurlygina, A; Litvinenko, G; Dergacheva, T; Trufakin, V. (2000). Changes in thymosin-alpha(1)content in patients with nonspecific gynecologic diseases depending on inflammation type and efficacy of antiinflammatory and immunomodulating therapy.. Bulletin of experimental biology and medicine, 130(9), 895-7.
MLA
Shurlygina, A, et al. "Changes in thymosin-alpha(1)content in patients with nonspecific gynecologic diseases depending on inflammation type and efficacy of antiinflammatory and immunomodulating therapy.." Bulletin of experimental biology and medicine, 2000.
RethinkPeptides
RethinkPeptides Research Database. "Changes in thymosin-alpha(1)content in patients with nonspec..." RPEP-00619. Retrieved from https://rethinkpeptides.com/research/shurlygina-2000-changes-in-thymosinalpha1content-in
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.